Answers are grounded in this paper and cite their sources.
The current epidemiological situation due to the SARS-CoV-2 pandemic affects many clinical aspects of managing patients with acute and chronic pain. Currently problems and controversies arise regarding treatment of acute pain and fever associated with the viral infection itself, introducing and / or continuing analgesics and coanalgesics, drug safety and possible interactions, conducting invasive procedures for pain management, follow-up at the pain clinic and possible chronic pain as a complication of the viral infection. The team of PASP experts have developed the position statement concerning the above-listed clinical issues in accordance with contemporary literature.
No takes yet. Share an insight, caveat, or question.
Kocot-Kępska et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: